Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to identify and characterize the bacteria causing acute otitis media episode in HIV-positive and HIV-negative children (>=3 months to <5 years) in South Africa. Middle ear fluid sampling either by tympanocentesis or by careful sampling of spontaneous otorrhoea will be done; nasopharyngeal aspirate and urine sample will also be collected from the subjects.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| HIV-negative Group | This group is sub-divided into two sub-groups. One sub-group includes HIV-negative/ presumed negative subjects with a new episode of acute otitis media who have not yet received antibiotic therapy for the episode and the other sub-group includes HIV-negative/ presumed negative subjects with treatment failure who have had a diagnosis of acute otitis media and showed no clinical improvement within 48-72 hours of antibiotic treatment. |
| |
| HIV-positive Group | This group is sub-divided into two sub-groups. One sub-group includes HIV-positive subjects with a new episode of acute otitis media who have not yet received antibiotic therapy for the episode and the other sub-group includes HIV-positive subjects with treatment failure who have had a diagnosis of acute otitis media and showed no clinical improvement within 48-72 hours of antibiotic treatment. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Middle ear fluid, nasopharyngeal aspirate and urine sample. | Procedure | Middle ear fluid, nasopharyngeal aspirate and urine sample collection. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Occurrence of bacterial pathogens isolated from middle ear fluid samples in HIV-positive and HIV-negative subjects. |
| Measure | Description | Time Frame |
|---|---|---|
| Occurrence of bacterial serotypes. | ||
| Antimicrobial susceptibility of different bacteria isolated from middle ear fluid samples as assessed by standard microbiological techniques. | ||
Not provided
Inclusion Criteria:
Inclusion criteria for all subjects:
Inclusion criteria for HIV-positive subjects:
Inclusion criteria for HIV-negative subjects (including presumed negative children)
Exclusion Criteria:
Not provided
Not provided
Children aged >= 3 months and < 5 years seeking healthcare for the treatment of acute otitis media.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| GSK Clinical Trials | GlaxoSmithKline | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Soweto | Gauteng | 2013 | South Africa |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 25923426 | Derived | Madhi SA, Govender N, Dayal K, Devadiga R, Van Dyke MK, van Niekerk N, Cutland CL, Adrian PV, Nunes MC. Bacterial and Respiratory Viral Interactions in the Etiology of Acute Otitis Media in HIV-infected and HIV-uninfected South African Children. Pediatr Infect Dis J. 2015 Jul;34(7):753-60. doi: 10.1097/INF.0000000000000733. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010033 | Otitis Media |
| ID | Term |
|---|---|
| D010031 | Otitis |
| D004427 | Ear Diseases |
| D010038 | Otorhinolaryngologic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Middle ear fluid, nasopharyngeal aspirate and urine.
| Occurrence of treatment failure of acute otitis media and of recurrent acute otitis media. |
| Occurrence of spontaneous otorrhoea. |
| Occurrence of bacteria in acute otitis media cases with treatment failure and in new acute otitis media cases without treatment therapy. |
| Occurrence of bacteria in acute otitis media cases vaccinated with a pneumococcal vaccine. |
| Frequency of concurrent respiratory viral infection coinciding with the episode of acute otitis media. |
| The comparison of above endpoints in HIV-positive and HIV-negative subjects. |